Related Experiment Video
Updated: May 3, 2026
08:51
Genome-wide RNAi Screening to Identify Host Factors That Modulate Oncolytic Virus Therapy
Published on: April 3, 2018
8.8K
Pediatric Oncology Knowledge Mobilization in Canada: Protocol for an Environmental Scan.
Emily K Drake1,2, Catherine Foulem3, Ekaterini Damoulianos1
1Ingram School of Nursing, Faculty of Medicine and Health Sciences, McGill University, Montréal, QC, Canada.
JMIR Research Protocols
|May 1, 2026
Summary
This study maps Canadian pediatric oncology nonprofits and their knowledge sharing. Findings will improve information access for childhood cancer patients and professionals, strengthening support networks.
Area of Science:
- Pediatric Oncology
- Nonprofit Organizations
- Knowledge Mobilization
Background:
- Nonprofit organizations are vital for disseminating information to the pediatric oncology community.
- Locating reliable resources is challenging due to varying information quality and misinformation online.
- Understanding knowledge mobilization by these Canadian organizations is limited.
Purpose of the Study:
- To overview the pediatric oncology nonprofit landscape in Canada.
- To describe their knowledge mobilization and dissemination efforts.
- To identify strengths, gaps, and opportunities for collaboration.
Main Methods:
- An environmental scan methodology will search government and nonprofit databases.
- Independent reviewers will screen eligible organization websites.
- Data will be descriptively analyzed, geographically sorted, and presented.
Main Results:
- Project funded in 2024, with preliminary results expected by summer 2025.
- Search strategy completion in spring 2025, with expert consultations.
- Final manuscript submission anticipated in fall 2025.
Conclusions:
- The environmental scan will detail methods for others to learn from.
- Findings will be disseminated broadly via social media, networks, and academic outputs.
- This will enhance navigation of resources and bolster knowledge mobilization capacity in Canada.
More Related Videos
Related Concept Videos
01:24Pharmacokinetics in Pediatric Patients: Drug Metabolism
410
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
410
01:26Pharmacokinetics in Pediatric Patients: Drug Excretion
408
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
408
01:23Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
967
Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
967
01:17Pharmacokinetics in Pediatric Patients: Drug Distribution
554
Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
554
01:21Cancer Survival Analysis
863
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
863
02:59Cancer Prevention
2.6K
2.6K